Circumference Group’s UiPath PATH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.8M Sell
350,000
-75,000
-18% -$801K 8.26% 6
2026
Q1
$4.72M Buy
425,000
+40,000
+10% +$509K 10.57% 4
2025
Q4
$6.31M Buy
385,000
+120,000
+45% +$1.87M 6.8% 4
2025
Q3
$3.55M Sell
265,000
-135,000
-34% -$1.6M 3.96% 13
2025
Q2
$5.12M Sell
400,000
-50,000
-11% -$600K 5.31% 8
2025
Q1
$4.63M Buy
450,000
+85,000
+23% +$1.09M 5.68% 8
2024
Q4
$4.64M Buy
365,000
+75,000
+26% +$991K 3.99% 13
2024
Q3
$3.71M Buy
290,000
+50,000
+21% +$612K 3.85% 12
2024
Q2
$3.04M Buy
+240,000
New +$4.15M 3.21% 13
2024
Q1
Sell
-30,000
Closed -$745K 35
2023
Q4
$745K Buy
+30,000
New +$586K 0.66% 27

Other funds holding PATH

Circumference Group's PATH Position: Q2 2026 in Review

Circumference Group reduced its UiPath (PATH) stake by 18% in Q2 2026, selling an estimated $801K and leaving 350,000 shares worth $3.8M. The position accounts for 8.26% of the portfolio, ranked #6.

Circumference Group first reported a position in PATH in Q4 2023 and has held it in 10 quarters since. The position peaked at $6.31M in Q4 2025. 529 funds tracked by Wall St. Rank hold PATH as of Q2 2026.

  • Circumference Group held 350,000 shares of UiPath worth $3.8M as of Q2 2026.
  • Circumference Group sold 75,000 UiPath shares in Q2 2026, an estimated $801K.
  • UiPath made up 8.26% of Circumference Group's portfolio in Q2 2026, its #6 holding.
  • Circumference Group first reported a position in UiPath in Q4 2023 and has held it in 10 quarters since.
  • Circumference Group's UiPath position peaked at $6.31M in Q4 2025.
  • 529 funds tracked by Wall St. Rank held UiPath as of Q2 2026.

Based on Circumference Group's 13F filing for Q2 2026, filed 14 Aug 2026.